Enstilar® foam spray is designed to be sprayed onto your skin. Simply apply where your doctor has indicated, following these simple steps:

Close-up images of patients with psoriasis before treatment and 4 weeks after treatment

1. Remove the cap and shake the can for a few seconds before use. Wash and dry hands before application.

2. Apply the foam by holding the can at least 3 cm (just over 1 inch) from the skin and spray directly onto each affected area. Spray the foam by holding the can in any direction except horizontally (on its side).

3. Gently rub the foam spray into each affected skin area.

PSORIASIS RELIEF IN A

CANSHAKE RUBSPRAY

This leaflet is intended for patients prescribed Enstilar® (calcipotriol/betamethasone

dipropionate cutaneous foam).

This leaflet does not replace the Patient Information

Leaflet (PIL) provided with your medicine which you

should always read carefully.

Enstilar® contains calcipotriol and betamethasone dipropionate (50 micrograms/g + 0.5 mg/g) in a foam spray formulation.

• Enstilar® is a foam spray plaque psoriasis treatment that comes in a can

• Just spray it on once a day for 4 weeks and your psoriasis may begin to clear

…AND REMEMBER • Don’t use more than 15 grams per day

• Spraying for 2 seconds provides approximately 0.5 g of Enstilar® foam spray and this should cover an area of skin roughly corresponding to the surface area of an adult hand

• Caution: Extremely flammable aerosol. Protect from sunlight and do not store above 30°C. The can should be discarded 6 months after first opening

WANT TO FIND OUT MORE?QualityCareTM is a free website, providing information and support on psoriasis, and treatment with Enstilar® foam spray.

For more information on Enstilar® foam spray, including Frequently Asked Questions (FAQs) plus lots of handy Hints & Tips on how to get the most out of your treatment, visit

qcbyleo.uk/6

HIP

FORE

ARM

BASELINE WEEK 4

REPORTING OF SIDE EFFECTSIf you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard

By reporting side effects you can help provide more information on the safety of this medicine.

UK MAT-07593

Date of Preparation: February 2017

Created by